According to the Complaint, RTI Surgical Holdings, Inc. purports to operate as a surgical implant company that designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. On March 8, 2019, RTI Surgical, Inc. acquired Paradigm Spine, LLC, a company focused on spinal infusion technology. The resultant company reorganized itself as RTI Surgical Holdings, Inc.

The Complaint alleges that Defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the Company inappropriately recognized revenues with respect to certain contractual arrangements, including other equipment manufacturer customers; (2) the Company's internal controls over financial reporting were not effective; (3) as a result, the Company would be forced to delay the filing of its Form 10-K for fiscal year ended December 31, 2019; and (4) as a result, Defendants' statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On June 30, 2020, the Court issued an Order appointing Lead Plaintiff and Counsel. Lead Plaintiff filed a consolidated amended Complaint on August 31. Defendants filed Motions to Dismiss the consolidated amended Complaint on October 15. On April 1, 2021, the Court issued an Order denying Defendants' Motions to Dismiss.

The parties entered into a Stipulation and Agreement of Settlement on August 31, 2021. On September 22, the Court granted preliminary approval of the Settlement. The Court granted final approval of the Settlement and entered Final Judgment on January 26, 2022. The Court's Order included an award of Attorneys' Fees and Expenses to the Plaintiff's Lead Counsel. On September 3, the Court issued an Order approving distribution of the net Settlement fund.

On November 15, 2023, the Court authorized distribution of the remaining funds on a cy pres basis.